Literature DB >> 26788840

Development of Splice Variant-Specific Monoclonal Antibodies Against Human α3 Integrin.

Teruaki Oku1, Yusuke Ando1, Masaharu Ogura1, Tsutomu Tsuji1.   

Abstract

Integrins are a major family of adhesion molecules, consisting of heterodimers (α and β subunits). Several reports have suggested the presence of splice variants in the cytoplasmic domain of certain integrin subunits. In the present study, we detected mRNA of integrin α3 splice variants (α3A and α3B) by RT-PCR using total RNA from the human brain as a template. The α3B variant lacks the sequence coded by exon 25 and appears to be generated by alternative splicing. We established mouse hybridomas producing monoclonal antibodies (both of which are of IgG1 class) specific for each variant. Each antibody exhibited specific reactivity towards the corresponding integrin α3 variant in Western blotting and immunoprecipitation experiments, suggesting it to be a useful tool for detection of the respective integrin variant.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26788840     DOI: 10.1089/mab.2015.0053

Source DB:  PubMed          Journal:  Monoclon Antib Immunodiagn Immunother        ISSN: 2167-9436


  3 in total

Review 1.  Single domain antibodies for the knockdown of cytosolic and nuclear proteins.

Authors:  Thomas Böldicke
Journal:  Protein Sci       Date:  2017-03-24       Impact factor: 6.725

2.  Sulfated Hyaluronan Binds to Heparanase and Blocks Its Enzymatic and Cellular Actions in Carcinoma Cells.

Authors:  Jia Shi; Riku Kanoya; Yurina Tani; Sodai Ishikawa; Rino Maeda; Sana Suzuki; Fumiya Kawanami; Naoko Miyagawa; Katsuhiko Takahashi; Teruaki Oku; Ami Yamamoto; Kaori Fukuzawa; Motowo Nakajima; Tatsuro Irimura; Nobuaki Higashi
Journal:  Int J Mol Sci       Date:  2022-05-02       Impact factor: 6.208

3.  Effects of sterol derivatives in cationic liposomes on biodistribution and gene-knockdown in the lungs of mice systemically injected with siRNA lipoplexes.

Authors:  Yoshiyuki Hattori; Hiromu Saito; Teruaki Oku; Kei-Ichi Ozaki
Journal:  Mol Med Rep       Date:  2021-06-24       Impact factor: 2.952

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.